These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2964166)

  • 1. Dopamine D2-receptor affinities of resolved C1-dimethylated 2-aminotetralins.
    Krotowska A; Nordvall G; Mellin C; Johansson AM; Hacksell U
    Acta Pharm Suec; 1987; 24(4):145-52. PubMed ID: 2964166
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.
    Beart PM; Cook CJ; Cincotta M; de Vries DJ; Tepper P; Dijkstra D; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):487-93. PubMed ID: 2963964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR of N-alkylated 2-aminotetralins as central dopamine receptor stimulating agents.
    Lien EJ; Nilsson JL
    Acta Pharm Suec; 1983; 20(4):271-6. PubMed ID: 6637518
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
    J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract]   [Full Text] [Related]  

  • 7. N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonists.
    Beaulieu M; Itoh Y; Tepper P; Horn AS; Kebabian JW
    Eur J Pharmacol; 1984 Oct; 105(1-2):15-21. PubMed ID: 6237927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the (+) and (-)-enantiomers of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene on dopamine receptors and on dopamine uptake [proceedings].
    Andrews CD; Davis A; Freeman HS; McDermed JD; Poat JA; Woodruff GN
    Br J Pharmacol; 1978 Nov; 64(3):433P. PubMed ID: 719283
    [No Abstract]   [Full Text] [Related]  

  • 9. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 10. Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivity.
    van Vliet LA; Tepper PG; Dijkstra D; Damsma G; Wikström H; Pugsley TA; Akunne HC; Heffner TG; Glase SA; Wise LD
    J Med Chem; 1996 Oct; 39(21):4233-7. PubMed ID: 8863800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
    Seiler MP; Stoll AP; Closse A; Frick W; Jaton A; Vigouret JM
    J Med Chem; 1986 Jun; 29(6):912-7. PubMed ID: 3712381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-mimetic activity of some aminotetralins, as revealed by the production of cyclic AMP in rabbit retina in vitro.
    Schorderet M; McDermed J
    Adv Biochem Psychopharmacol; 1978; 19():351-5. PubMed ID: 211816
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
    Hoffmann IS; Naylor RJ; Cubeddu LX
    J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of dopamine agonists.
    Cannon JG
    Annu Rev Pharmacol Toxicol; 1983; 23():103-29. PubMed ID: 6347047
    [No Abstract]   [Full Text] [Related]  

  • 17. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA; Seeman P
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

  • 19. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of 3-PPP to activate dopamine autoreceptors in vitro.
    Sminia P; Mulder AH
    Eur J Pharmacol; 1983 Apr; 89(1-2):183-4. PubMed ID: 6861887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.